We are live on
!
Find out more
OC
Oppenheimer & Co Portfolio holdings
AUM
$8.21B
1-Year Est. Return
28.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
(-5.4%)
Cap. Flow
-$341M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$7.02M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$6.58M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.15M |
| 4 |
Bank of America
BAC
|
+$3.47M |
| 5 |
Thor Industries
THO
|
+$3.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
+$63.6M |
| 2 |
Gilead Sciences
GILD
|
+$42.5M |
| 3 |
Aflac
AFL
|
+$39.9M |
| 4 |
CarMax
KMX
|
+$23.6M |
| 5 |
John Wiley & Sons Class A
WLY
|
+$19.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.63% |
| 2 | Healthcare | 11.47% |
| 3 | Financials | 11.29% |
| 4 | Industrials | 9.35% |
| 5 | Consumer Discretionary | 8.08% |
Similar funds
LGF
CCM
CL
WJWM
CLOS
WA
CCM
KPWS
Oppenheimer & Co's Q2 2018 Portfolio in Review
As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.
- Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
- Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
- Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
- Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
- Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
- Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
- Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.
Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.